Citadel Advisors »

Gracell Biotechnologies shares owned by Citadel Advisors

Quarter-by-quarter ownership of Gracell Biotechnologies shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Gracell Biotechnologies

Tip: Access up to 7 years of quarterly data

All positions including Gracell Biotechnologies held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gracell Biotechnologies by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $652k 65k 10.04
2022-03-31 $126k 54k 2.32
2021-09-30 $243k 18k 13.87
2021-06-30 $527k 41k 13.02
2021-03-31 $595k 39k 15.37

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Gracell Biotechnologies

OrbiMed Advisors
Tang Capital Management
Baker Bros. Advisors
Pentwater Capital Management
TIG Advisors
Alpine Associates Management
Octagon Capital Advisors
Bank of America Corporation
LMR Partners
Sphera Funds Management
MMCAP International Inc. SPC
Hudson Bay Capital Management
Marshall Wace
Millennium Management
CNH Partners

View all funds holding Gracell Biotechnologies